Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode
    Strategic win for Control Bionics as new HCPCS gets approved for NeuroNode
    • News

  • PharmAust invited by FightMND to submit a funding request for up to $1.8m
    PharmAust invited by FightMND to submit a funding request for up to $1.8m
    • News

  • Drug that stops growth of cancerous cells shows positive results
    Drug that stops growth of cancerous cells shows positive results
    • News

  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • News

  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma
    A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma
    • News

  • This ‘proptech’ is transforming the way we buy and sell homes
    • News

    This ‘proptech’ is transforming the way we buy and sell homes

    Almost every industry has been forced to pivot and adapt to the increasingly digital world in the wake of COVID-19. Self proclaimed ‘proptech’, Openn Negotiation (ASX: OPN) offers a platform for the real estate industry to operate online. The Openn cloud-based software platform supports real estate agents to sell properties by facilitating negotiation, contracting and

    Read More
    Public
  • Former Air Force Captain appointed by Crowd Media for commercialisation takeoff
    • News

    Former Air Force Captain appointed by Crowd Media for commercialisation takeoff

    President of the United States, Royal Family and now Crowd Media (ASX: CM8). It may not be a linear progression but the disruptive artificial intelligence company is following the time-tested trend of appointing an exceptional military leader to drive its next phase of growth with Idan Schmorak confirmed as its new CEO.  A former officer

    Read More
    Public
  • Bendigo and Adelaide Bank to expand quickfire home loans with Ferocia fintech acquisition
    • News

    Bendigo and Adelaide Bank to expand quickfire home loans with Ferocia fintech acquisition

    With house prices across Australia continuing to soar, the market for home loans is heating up as the major banks seek to capture the younger tech-savvy generation with Bendigo and Adelaide Bank (ASX: BEN) confirming their acquisition of fintech business Ferocia for $116 million. The acquisition is driven by Bendigo Bank’s response to changes in

    Read More
    Public
  • West Virginia… mountain mama… Take me home, to get my bet on…
    • News

    West Virginia… mountain mama… Take me home, to get my bet on…

    Country roads, take me home, to the place I belong, West Virginia…. mountain mama, Take me home, to get my bet on… A slight tweak to the John Denver classic could soon be a new theme song for the Mountain State with bookmaker PointsBet (ASX: PBH) securing regulatory approval to commence its sports betting operations

    Read More
    Public
  • Cancer drug development company gathering momentum as more researchers worldwide take notice
    • News

    Cancer drug development company gathering momentum as more researchers worldwide take notice

    With promising data starting to flow from clinical trials, more and more medical researchers are tuning in to the Pharmaxis (ASX: PXS) story. The drug development Company has a diverse pipeline backed by solid science with drugs engineered by their world renowned drug development team. Lead drug candidate PXS-5505 is designed to treat myelofibrosis, aRead More
    Public
  • Unanimous Board support for merger to create vocational education giant
    • News

    Unanimous Board support for merger to create vocational education giant

    The new kids on the block in the higher education sector continue to make waves at a time when their traditional rivals are being forced to slash jobs with confirmation that the proposed merger of iCollege (ASX: ICT) and RedHill Education (ASX: RDH) has received unanimous support from both Board of Directors. The merger will

    Read More
    Public
  • Blood test or crystal ball? Looking into the future of our health
    • News

    Blood test or crystal ball? Looking into the future of our health

    An estimated 1.2 million Australians are living with diabetes, a serious chronic disease with numerous complications and comorbidities including diabetic kidney disease (DKD). The risk factors for developing DKD are well known, but could we treat people better if we knew more about their personal risk factors, or predict the likelihood of future functional decline

    Read More
    Public
  • Austal – from where you’d rather be
    • News

    Austal – from where you’d rather be

    Your journalist would prefer to be on the sandy white beaches of Tahiti right now, sipping a cool mojito and sizzling in the sun.  But, with a long expired passport that won’t be renewed anytime soon, I’m bound to my inner city apartment.  Teasing me, and those locked down across the country is Austal Limited

    Read More
    Public
  • ISA to expand VR gaming for use in military and defence training
    • News

    ISA to expand VR gaming for use in military and defence training

    The ultra realism of first person shooter (FPS) gaming could take on a whole new level with virtual reality entertainment company ISA Group (ASX: IDZ) acquiring VR production studio Red Cartel with the intent of developing VR for use in military and defence operations. Unlike ISA whose primary VR tech is designed for consumer entertainment

    Read More
    Public
  • US Infrastructure Bill sees markets higher
    • News

    US Infrastructure Bill sees markets higher

    Overnight the S&P500 and Dow closed higher as Financials, Energy Industrial and Materials push higher on the back of Bidens 550 billion in infrastructure spending. This will help see the US economy rebound after Covid and opens the door for the Democrats to approve a 3.5 trillion budget to spend further on their social security

    Read More
    Public
  • «
  • ‹
  • 227
  • 228
  • 229
  • 230
  • 231
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.